Annemieke Geluk mainly focuses on Antigen, Mycobacterium tuberculosis, Virology, Epitope and Immunology. Her research is interdisciplinary, bridging the disciplines of Peptide and Antigen. Her Mycobacterium tuberculosis study deals with Cytotoxic T cell intersecting with Human leukocyte antigen and HLA-E.
Her Immune system research extends to the thematically linked field of Virology. Her Epitope study combines topics in areas such as Molecular biology, DNA vaccination and T cell. Her Immunology study frequently links to other fields, such as Tuberculosis.
Annemieke Geluk mainly investigates Immunology, Leprosy, Mycobacterium leprae, Antigen and Virology. Annemieke Geluk regularly links together related areas like Tuberculosis in her Immunology studies. Her Leprosy study combines topics from a wide range of disciplines, such as Transmission, Humoral immunity, Disease, Biomarker and Serology.
Her Mycobacterium leprae study integrates concerns from other disciplines, such as Infectious disease, Pathogen, Microbiology, Mycobacterium and Peripheral blood mononuclear cell. Her studies in Antigen integrate themes in fields like Recombinant DNA and Mycobacterium tuberculosis. Her study explores the link between Virology and topics such as Cytotoxic T cell that cross with problems in CD8 and HLA-E.
The scientist’s investigation covers issues in Leprosy, Mycobacterium leprae, Immunology, Biomarker and Disease. Her Leprosy research integrates issues from Epidemiology, Cohort study, Transmission, Antibody and Polymerase chain reaction. She interconnects Infectious disease, Pathogen, Microbiology, Genotype and Sanger sequencing in the investigation of issues within Mycobacterium leprae.
Her research on Immunology often connects related areas such as Tuberculosis. Her research in Mycobacterium tuberculosis intersects with topics in Progressive disease, Genetic predisposition and Antigen. In general Antigen, her work in CD8 is often linked to Research development linking many areas of study.
Her scientific interests lie mostly in Leprosy, Mycobacterium leprae, Immunology, Biomarker and Disease. Her work carried out in the field of Leprosy brings together such families of science as Subclinical infection and Environmental health. Her Mycobacterium leprae research includes themes of Disease reservoir, Microbiology, Gene signature and Gene, Polymerase chain reaction.
The concepts of her Immunology study are interwoven with issues in Tuberculosis and Mycobacterium tuberculosis. Her biological study spans a wide range of topics, including Progressive disease, Clinical trial, Genetic predisposition and Antigen. Her research investigates the connection between Disease and topics such as Transmission that intersect with issues in Serology, Cellular immunity and Humoral immunity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1
Coenraad Kuijl;Nigel D. L. Savage;Marije Marsman;Adriaan W. Tuin.
Antigenic Equivalence of Human T-Cell Responses to Mycobacterium tuberculosis-Specific RD1-Encoded Protein Antigens ESAT-6 and Culture Filtrate Protein 10 and to Mixtures of Synthetic Peptides
Sandra M. Arend;Annemieke Geluk;Krista E. van Meijgaarden;Jaap T. van Dissel.
Infection and Immunity (2000)
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
Sjoerd H. van der Burg;Maaike E. Ressing;Kitty M.C. Kwappenberg;Annemieke de Jong.
International Journal of Cancer (2001)
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.
Simone A. Joosten;Krista E. van Meijgaarden;Nigel D. L. Savage;Tjitske de Boer.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
Maytal Bivas-Benita;Krista E. van Meijgaarden;Kees L.M.C. Franken;Hans E. Junginger.
Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans
A. Geluk;K. E. van Meijgaarden;K. L. M. C. Franken;J. W. Drijfhout.
Journal of Immunology (2000)
Frequent Detection of Human Papillomavirus 16 E2-specific T-helper Immunity in Healthy Subjects
Annemieke de Jong;Sjoerd H. van der Burg;Kitty M. C. Kwappenberg;Jeanette M. van der Hulst.
Cancer Research (2002)
Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis.
Annemieke Geluk;Krista E. van Meijgaarden;Kees L. M. C. Franken;Yanri W. Subronto.
Infection and Immunity (2002)
Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity
Simone A Joosten;Krista E van Meijgaarden;Pascale C van Weeren;Fatima Kazi.
PLOS ONE (2010)
Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8+ T-cells with cytotoxic as well as regulatory activity.
Simone A. Joosten;Krista E. van Meijgaarden;Pascale C. van Weeren;Fatima Kazi.
PLOS Pathogens (2010)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: